QUALITATIVE REVIEW OF ANTIBIOTIC USE FOR NEONATAL SEPSIS by Wei, Tjio Ie et al.
ISSN - 0975-7058 
Vol 10, Special Issue 1, 2018
QUALITATIVE REVIEW OF ANTIBIOTIC USE FOR NEONATAL SEPSIS
TJIO IE WEI1, PURWANTYASTUTI ASCOBAT1, RINAWATI ROHSISWATMO2, INSTI INSTIATY1*
1Department of Pharmacology and Therapeutics, Faculty of Medicine, Universitas Indonesia, Jakarta, 10430, Indonesia. 2Department of 
Child Health, Faculty of Medicine, Universitas Indonesia, Jakarta, 10430, Indonesia. Email: instiaty@yahoo.com
Received: 06 August 2018, Revised and Accepted: November 2018
ABSTRACT
Objective: The aim of this study is to evaluate the antibiotic use in neonates with sepsis.
Methods: An observational retrospective study was conducted using medical records of neonates diagnosed with early-/late-onset sepsis who were 
prescribed antibiotics and who were treated in the neonatal intensive care unit (NICU) at the Dr. Cipto Mangunkusumo Hospital between January 1 and 
December 31, 2015. Patient records were screened for antibiotic use; qualitative analyses were performed using the Gyssens algorithm. Concordance 
of empirical antibiotic prescriptions with subsequent blood culture and sensitivity tests was evaluated.
Results: A total of 176 sepsis cases included 80 and 96 neonates with normal and low birth weights (LBWs), respectively. Ampicillin-
sulbactam+gentamycin, which is indicated in local guidelines as the first-line antibiotic combination for neonatal sepsis, was most frequently 
prescribed. In the normal birth weight group, appropriate antibiotic use (Gyssens Category I) was found in 89.7% of cases, whereas Gyssens Category V 
(no indication) was found in 4.54% of cases. In the LBW group, 88.1% and 6.2% of cases were included in Gyssens Categories I and V, respectively. 
Only 17.5% and 13.5% cultured blood specimens from normal and LBW groups, respectively, yielded positive results; the most commonly identified 
bacteria were Acinetobacter baumannii and Klebsiella pneumonia. All isolates were resistant to ampicillin-sulbactam; only 7.4% were sensitive to 
gentamicin.
Conclusion: Antibiotic use for neonatal sepsis in NICU in this study can be considered appropriate, suggesting proper implementation of antimicrobial 
guidelines. However, high rates of resistance to the first-line antibiotics for neonatal sepsis are concerning.
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INTRODUCTION
Neonatal sepsis follows invasive infection, usually bacterial, that occurs 
during the neonatal period. In a report from the WHO, the case fatality 
rate of neonatal sepsis was estimated at approximately 40% [1,2]. 
Although antibiotic treatments should be initiated immediately on 
suspicion of neonatal sepsis [3-6], in 20–30% of neonatal cases of sepsis, 
antibiotics are unnecessarily prescribed and may increase morbidity, 
health-care costs, and resistance to antimicrobials. Hence, to ensure 
appropriate prescriptions, such prescriptions should be monitored and 
evaluated regularly. To this end, an antimicrobial resistance control 
program was implemented at the Dr. Cipto Mangunkusumo Hospital 
(RSCM) Jakarta, in 2009, although the appropriateness of antibiotic 
use in neonates with sepsis has not been assessed in the neonatal 
intensive care unit (NICU). Herein, we performed qualitative analyses 
of antibiotic use in neonates with sepsis who were treated in the NICU 
at RSCM.
METHODS
An observational retrospective study was performed using the records 
of neonates with sepsis who were treated in the NICU at RSCM between 
January 1 and December 31, 2015. The included neonates were 
diagnosed with clinical sepsis or had abnormal sepsis marker levels 
that were indicative of early-onset neonatal sepsis (EONS) appearing 
in the first 72 h after birth or late-onset neonatal sepsis (LONS) 
appearing at ≥72 h after birth, and were treated with antibiotics [3]. 
Neonates with birth weights of <1500 g were excluded from the study 
and the diagnoses in medical records were considered accurate. This 
study was approved by the Ethics Committee of the Faculty of Medicine 
Universitas Indonesia (No. 733/UN2.F1/ETIK/2016). Gestational ages, 
birth weights, details of labor (spontaneous, cesarean section), types 
of sepsis (EONS or LONS), types, frequencies, doses, and routes of 
antibiotic administration and results of culture, and sensitivity tests 
were included in the analyses.
Qualitative evaluations of antibiotic use were performed using the 
Gyssens algorithm, through which antibiotic use is divided into the 
following six categories: Category I, appropriate use; Categories II a, II b, 
or II c, inappropriate dose, dosing interval, or route of administration, 
respectively; Categories III a or III b, inappropriately long or short 
duration of treatment, respectively; Categories IV a, IV b, IV c, or 
IV d, more effective, less toxic, less expensive, or narrower spectrum 
of available antibiotics, respectively; Category V, no indication for 
antibiotics, and Category VI, antibiotic use not supported by sufficient 
data.
The appropriateness of the antibiotic use was determined with 
reference to the Pediatric Department Guidelines of Clinical Practice at 
RSCM, the Royal Women’s Hospital Neonatal Pharmacopoeia, the Drug 
Dose by Shann, the profile of bacterial and antibiotic susceptibility at 
RSCM, and other relevant references [7-9]. A pediatric neonatologist 
was also consulted during evaluations.
RESULTS AND DISCUSSION
A total of 176 sepsis cases included 96 neonates with low birth weight 
(LBW) (LBW, <2500 g) and 80 with normal birth weight (NBW) (NBW, 
≥2.500 g), and total numbers of antibiotic prescriptions were 925 for 
the NBW group and 1505 for the LBW group. Table 1 shows profiles of 
neonates with sepsis treated in the NICU at RSCM in 2015.
The most commonly administered antibiotic preparation in the 
NBW (400 prescriptions) and LBW groups (524 prescriptions) was 
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ampicillin-sulbactam+gentamycin, which is the first-line empirical 
antibiotic for neonatal sepsis according to the 2015 guidelines for 
antibiotic use in the Pediatric Department at RSCM. The second 
most widely prescribed antibiotic preparation was piperacillin-
tazobactam+amikacin, with 219 prescriptions for the NBW and 462 
prescriptions for the LBW groups. This preparation is listed in the 
guidelines for antibiotic use in the Pediatric Department, RSCM, as the 
second-line empirical antibiotic treatment for neonatal sepsis, followed 
by meropenem, for which 124 and 193 prescriptions were recorded 
for the NBW and LBW groups, respectively. Table 2 lists antibiotics 
prescriptions for neonates with sepsis in the NICU at RSCM during 2015.
Qualitative evaluations of antibiotic use were performed using the 
Gyssens algorithm and are presented in Tables 3 and 4. In the NBW 
group, antibiotic usage was categorized appropriate (Category I) in 
830 cases (90.4%), and 2 cases (0.2%) were placed in Category III A, 
25 (2.7%) in Category IV D, 6 (0.7%) in Category IV C, 13 (1.4%) in 
Category IV A, and 42 (4.6%) in Category V (no indication to use 
antibiotics; Table 3).
In the LBW group, 1326 of 1505 antibiotic prescriptions (88.1%) 
were categorized as appropriate (Gyssens Category I), and 8 (0.5%) 
were placed in Category III A, 61 (4.1%) in Category IV B, 17 (1.1) 
in Category IV D, and 93 (6.2%) in Category V (no indication for 
antibiotics; Table 4).
Blood cultures were performed for all the NBW and LBW neonates 
with sepsis before antibiotic administration and proportions of 
bacterial cultures that yielded positive results were relatively low. In 
the LBW group, 13 of the 96 patients had positive bacterial cultures 
(13.5%), whereas 14 of the 80 patients (17.5%) in the NBW group had 
positive results. Overall, the most common bacteria were Acinetobacter 
baumannii and Klebsiella pneumonia (each 18.5%), Escherichia coli 
and Serratia marcescens (each 14.5%), and Staphylococcus epidermidis 
(11.1%). Of the 27 isolates, all were resistant to ampicillin-sulbactam 
and 7.4% only were sensitive to gentamicin, 11.1% only were sensitive 
to piperacillin-tazobactam, 14.8% only were sensitive to amikacin, and 
25.9% only were sensitive to meropenem.
DISCUSSION
According to the local 2015 guidelines for clinical practice in the 
Department of Pediatrics at RSCM, the first-line, second-line, and 
third-line antibiotics for the treatment of neonatal sepsis were 
ampicillin-sulbactam+gentamicin, piperacillin-tazobactam+amikacin, 
and meropenem, respectively [7]. In the present study, the three most 
frequently used antibiotics for neonates with sepsis were in strict 
accordance with the first-, second-, and third-line antibiotics listed for 
those conditions in the local guidelines, implying that the guidelines 
were well implemented.
Antibiotic use in the neonates with sepsis was appropriate (Gyssens 
Category 1) in almost 90% of the cases, although antibiotics were 
prescribed for some patients without indications (Gyssens Category V). 
In these cases, the antibiotics were prescribed following the failure of 
empirical antibiotics to improve clinical symptoms, despite negative 
bacterial cultures.
This is the first study of antibiotic use specifically in neonatal sepsis 
patients at the RSCM. Satari et al. qualitatively evaluated antibiotic 
use in the pediatric ward at the RSCM during 2009 and showed that 
antibiotics were used appropriately in 39.6% of cases only [10]. In the 
incipient antibiotic use study by Pamela, appropriate antibiotic use was 
Table 3: Antibiotic use for neonatal sepsis in the NBW group based on Gyssens categories
Antibiotics Gyssens criteria Total
I II III IV V VI
1st line 400 - - - - 400
2nd line 186 - 2 31 - - 219
3rd line 118 - - 6 - - 124
Imipenem 0 - - - 32 - 32
Cefoperazone 45 - - - - - 45
Cefepime 81 - - - 10 - 91
Cefoperazone-sulbactam 7 - - 7 - - 14
Total (%) 830 (89.7) 0 2 (0,22) 44 (4.8) 42 (4.54) 0 925 (100)
1st line, ampicillin-sulbactam+gentamycin; 2nd line, piperacillin-tazobactam+amikacin, 3rd line, meropenem, NBW: Normal birth weight
Table 2: Antibiotics prescribed for neonates with sepsis in the 
NICU at RSCM during 2015
No. Antibiotics Number of 
prescriptions (%)
NBW (n=80) LBW (n=96)
1. Ampicillin-sulbactam+gentamicin 400 (43.2) 524 (34.8)
2. Piperacillin-tazobactam+amikacin 219 (23.7) 462 (30.7)
3. Meropenem 124 (13.4) 193 (12.8)
4. Cefepime 91 (9.8) 71 (4.7)
5. Cefoperazone 45 (4.9) 30 (2.0)
6. Imipenem 32 (3.5) 47 (3.1)
7. Cefoperazone-sulbactam 14 (1.5) 6 (0.4)
8. Ampicillin-sulbactam - 7 (0.5)
9. Gentamicin - 31 (2.1)
10. Amikacin 54 (3.6)
11. Metronidazole - 30 (2.0)
12. Tigecycline - 35 (2.3)
13. Levofloxacin - 15 (1.0)
Total 925 1505
NBW: Normal birth weight, LBW: Low birth weight, n: Number of patients
Table 1: Profile of neonates with sepsis in the NICU at RSCM 
during 2015
No. Characteristic NBW LBW
n (%) n (%)
1 Sepsis neonates
EONS 78 (81.25) 84 (87.5)
LONS 18 (18.75) 12 (12.5)
2 Gestational age (weeks)
<37 18 (18.75) 93 (96.87)
≥37 78 (81.25) 3 (3.13)
3 History of parturient
Section cesarian 60 (62.5) 57 (59.38)
Spontaneous 36 (37.5) 39 (40.62)
4 Outcome
Recover 91 (94.79) 80 (83.33)
Death 5 (5.21) 16 (16.67)
EONS: Early-onset neonatal sepsis, LONS: Late-onset neonatal sepsis, 
NBW: Normal birth weight, LBW: Low birth weight
 The 2nd Physics and Technologies in Medicine and Dentistry Symposium (PTMDS), Universitas Indonesia. Depok, Indonesia 366
Int J App Pharm, Vol 10, Special Issue 1, 2018
 Tjio et al. 
recorded in 60.4% of pediatric patients in the pediatric ward at the 
RSCM [11]. Encouragingly, the present rate of appropriate antibiotic was 
almost 90%, suggesting continued improvement in our department, 
although the subjects of this study were limited to neonates with sepsis.
Of great concern is all the isolates were resistant to ampicillin-
sulbactam, which is, in combination with gentamicin, classified as the 
first-line antibiotic treatment for neonatal sepsis. Resistance to the 
second- (piperacillin-tazobactam+amikacin) and third-line antibiotics 
(meropenem) was also high. However, in this study, microbial cultures 
yielded positive results in 17.5% only of the specimens from the NBW 
group and in 13.5% only of the specimens from the LBW group. These 
data indicate the necessity of improvements in the success rates of 
microbial cultures to increase the accuracy of antimicrobial sensitivity 
assessments.
CONCLUSION
Antibiotic use for neonatal sepsis in the NICU at the RSCM during 
2015 was predominantly appropriate, reflecting good adherence to 
the guidelines for antimicrobial use. However, the results of bacterial 
cultures and sensitivity tests indicate the necessity of the regular 
evaluations of empirical antibiotic regimens for neonatal sepsis.
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Table 4: Antibiotic use for neonatal sepsis in the LBW group based on Gyssens categories
Antibiotics Gyssens category Total
I II III IV V VI
1st line 524 - - - - - 524
2nd line 423 - 6 17 16 - 462
3rd line 191 - 2 - - - 193
Imipenem - - - 11 36 - 47
Cefoperazone 28 - - - 2 - 30
Cefepime 62 - - - 9 - 71
Cefoperazone-sulbactam 6 - - - - - 6
Amikacin 54 - - - - - 54
Gentamicin 31 - - - - - 31
Ampicillin-sulbactam 7 - - - - - 7
Levofloxacin - - - 15 - - 15
Tigecycline - - - 35 - - 35
Metronidazole - - - - 30 - 30
Total (%) 1326 (88.1) 0 8 (0.5) 78 (5.2) 93 (6.2) 0 1505 (100)
1st line, ampicillin-sulbactam+gentamycin; 2nd line, piperacillin-tazobactam+amikacin; 3rd line, meropenem, LBW: Low birth weight
